• ZPR1 Phase Separation Disrupted by Bacterial Effector NleE:

  2026-06-28

  Ouyang et al. reveal that the bacterial effector NleE disrupts the liquid-liquid phase separation (LLPS) of host ZPR1, antagonizing the unfolded protein response of the endoplasmic reticulum (UPRER). This mechanism highlights a novel way pathogens evade host defenses by directly modulating transcriptional regulation at the level of phase-separated nuclear bodies.

• Dimethyloxalylglycine (DMOG): Technical Guide and Protocols

  2026-06-27

  Dimethyloxalylglycine (DMOG) provides researchers with a reliable, cell-permeable inhibitor to stabilize hypoxia-inducible factors for modeling oxygen sensing and hypoxia signaling pathways in vitro and in vivo. It is intended strictly for scientific research, including studies of inflammation and infection, and should not be used in diagnostic or therapeutic contexts.

• AI-10-49: CBFβ-SMMHC Inhibition in Acute Myeloid Leukemia Re

  2026-06-26

  AI-10-49 enables precise disruption of the CBFβ-SMMHC and RUNX1 interaction, unlocking targeted investigation and modulation of leukemogenic pathways in acute myeloid leukemia research. Its specificity, coupled with validated in vitro and in vivo workflows, makes it an indispensable tool for dissecting disease mechanisms and testing translational hypotheses.

• RNA Clean and Concentrator Kit: Precision RNA Purification S

  2026-06-26

  The RNA Clean and Concentrator Kit streamlines RNA purification from enzymatic reactions, delivering ultra-pure RNA for demanding molecular workflows. Its rapid spin column protocol enables high-throughput cleanup of both single- and double-stranded RNA, addressing reproducibility and downstream compatibility in advanced research applications.

• DFO (9H-1,8-Diazafluoren-9-one): Molecular Insights and Next

  2026-06-25

  Explore the biochemical mechanisms and advanced applications of DFO (9H-1,8-Diazafluoren-9-one) in forensic science. This in-depth article delivers unique molecular perspectives, protocol optimization tips, and critical insights not found in standard workflow guides.

• Bradykinin B2 Receptors Inhibit Ileal Peristalsis via Pressu

  2026-06-25

  This study provides the first direct evidence that bradykinin B2 receptor activation inhibits the peristaltic reflex in guinea pig ileum by increasing the pressure threshold required for peristalsis. These findings refine mechanistic understanding of enteric neurotransmission and have significant implications for hypertension and ACE inhibitor research.

• CUDC-907: Protocol Guidance for Dual PI3K and HDAC Inhibitio

  2026-06-24

  CUDC-907 enables precise, simultaneous inhibition of PI3K and histone deacetylase (HDAC) pathways in controlled in vitro cancer research. It is not validated for diagnostic, therapeutic, or clinical applications and should only be used as directed in cell-based workflows. Researchers should consult technical documentation and workflow best practices before introducing CUDC-907 into experiments.

• Gepotidacin: Transforming Antibiotic Resistance Research

  2026-06-23

  Explore how Gepotidacin, a first-in-class GSK2140944 antibiotic, advances antibacterial research through a unique mechanism and robust data. This article provides deep scientific insight, protocol guidance, and perspective beyond standard workflows.

• Cell Counting Kit-8 (CCK-8) Plus: Practical Assay Optimizati

  2026-06-23

  Cell Counting Kit-8 (CCK-8) Plus is designed for rapid, sensitive quantification of cell viability, proliferation, and cytotoxicity, using a WST-8 based tetrazolium salt assay. It is ideal for researchers needing reproducible results and faster workflows in cell-based studies, but should not be used where direct metabolic activity does not reflect true live cell number or in scenarios incompatible with tetrazolium reduction chemistry.

• EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecan

  2026-06-22

  This article offers an evidence-based exploration of EGTA (3,12-bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecane-1,14-dioic acid) (SKU B7195) for precise calcium chelation in cell viability, proliferation, and cytotoxicity workflows. Scenario-driven Q&A blocks address practical challenges and position APExBIO's high-purity EGTA as a reproducible, cost-effective solution for modulating calcium-dependent processes in biomedical research.

• DCPS as an m7G Biomarker Regulating Epithelial Cells in DFU

  2026-06-22

  Xiao et al. identified the decapping scavenger enzyme (DCPS) as a novel biomarker in diabetic foot ulcers (DFU), linking its regulation of N7-methylguanosine (m7G) RNA modification to impaired epithelial cell function. Their integrative approach highlights DCPS’s pivotal role in cell cycle control, proliferation, and migration, offering new avenues for DFU diagnosis and therapeutic intervention.

• Reframing IAP Antagonism: BV6 for Translational Oncology & B

  2026-06-21

  This thought-leadership article explores the mechanistic underpinnings and translational promise of BV6, a selective IAP antagonist, for advancing apoptosis-based strategies in cancer and endometriosis research. It synthesizes mechanistic insights, evidence-based protocol guidance, and strategic perspectives to empower translational researchers aiming for reproducibility, clinical relevance, and workflow innovation.

• ATRX Loss Increases Glioma Sensitivity to PDGFR Inhibition

  2026-06-20

  This study demonstrates that high-grade glioma cells lacking ATRX are markedly more sensitive to receptor tyrosine kinase (RTK) and PDGFR inhibitors. These findings highlight ATRX mutation status as a critical biomarker for therapeutic response, with practical implications for experimental design and clinical trial interpretation.

• Glycogen Colorimetric Assay Kit II: Advancing Precision in M

  2026-06-19

  Explore how the Glycogen Colorimetric Assay Kit II empowers rigorous, interference-resistant glycogen quantification in cutting-edge metabolism and exercise studies. Uncover protocol insights and the latest research advances for optimal assay use.

• Dual SMAD and Wnt Inhibition Enables Efficient iPSC-RGC Diff

  2026-06-19

  The referenced study introduces a chemically defined protocol using dual SMAD and Wnt pathway inhibition to achieve efficient, reproducible differentiation of human induced pluripotent stem cells (iPSCs) into retinal ganglion cells (RGCs). This methodological advance addresses longstanding challenges in RGC yield and purity, providing a robust platform for glaucoma and neurodegenerative disease research.

449 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page